Drugs / Absolute Alcohol
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT00656110 | Apr 2008 → Nov 2009 | restless legs syndrome | Lowcountry Infectious Diseases | Unknown | No outcome recorded |
Also used as a comparator or background therapy in 2 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 41 trial | ||||||
| Phase 4 | NCT06316908 Comparator | Feb 2020 → Jul 2022 | malignant pancreatic neoplasm | Sindh Institute of Urology and Transplantation | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT06858228 Comparator | Apr 2025 → Sep 2026 expected | chronic pain syndrome, osteoarthritis, knee | Federal University of São Paulo | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Absolute Alcohol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06316908 ↗ |
| Route | Other | “a solution of absolute alcohol was injected unilaterally into the celiac plexus under image guidance” NCT06316908 ↗ |